Acute Coronary Syndromes Complicating the First Infusion of Rituximab

IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma

David G. Maloney, Antonio J Grillo-López, Christine A. White et al. · Blood · 1997 · 1.7K citations

Medicine, Hematology, Oncology +14

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Laurie H. Sehn, Jane Donaldson, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2005 · 989 citations · Full text

Medicine, Hematology, Oncology +8

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

U. Winkler, Mark A. Jensen, Oliver Manzke et al. · Blood · 1999 · 658 citations

Life Sciences, Hematology, Immunology +17

Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia

Susan O’Brien, Hagop M. Kantarjian, Deborah A. Thomas et al. · Journal of Clinical Oncology · 2001 · 588 citations

Pharmacy, Oncology, Pharmacotherapy +17

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)

John C. Byrd · Blood · 2002 · 572 citations · Full text

Medicine, Oncology, Pharmacotherapy +10